Organization: Bishop's Univ

MSBi Valorisation introduces new management team

MSBi Valorisation (MSBiV) has selected a new management team to boost its pre-seed and seed-stage commercialization services to its member institutions. The new management team, led by Didier Leconte (president and GM), is introducing a wide range of support and services to members McGill Univ, the Univ of Sherbrooke, Bishop’s Univ and their affiliated research…

iNovia inks agreements with Alberta institutions

iNovia Capital — formerly MSBi Capital — is implementing its strategic plan to expand beyond its Quebec base with a series of collaborative agreements with several academic institutions, primarily in Alberta. The seed and early-stage venture capital fund recently launched its $107-million iNovia Investment Fund II LP and has signed cooperation agreements with AVAC Ltd,…

Mimetogen Pharmaceuticals receives series A financing

McGill Univ spinoff Mimetogen Pharmaceuticals Inc has received series A financing from a venture capital consortium led by Boston-based VIMAC Milestone Medica Fund. Also participating is original investor MSBi Capital, a seed and early-stage fund created to commercialize technologies from McGill, Univ of Sherbrooke and Bishop’s Univ. Mimetogen is currently developing therapeutic approaches for small…